Label Changes for:
Myozyme (alglucosidase alfa)
July 2012
Changes have been made to the ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – July 2012
ADVERSE REACTIONS
Postmarketing Experience
- nephrotic syndrome and proteinuria

